Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 4,294 | 4,046 | 4,010 | 4,878 | 13,193 |
| Gross Profit | 4,294 | 4,046 | 4,010 | 4,878 | 13,193 |
| Operating Expenses | 5,114 | 3,847 | 10,147 | 4,843 | 4,532 |
| Operating Income | -820 | 199 | -6,137 | 35 | 8,661 |
| Other Income | -3,007 | 969 | -3,019 | 1,189 | 530 |
| Pre-tax Income | -3,827 | 1,168 | -9,156 | 1,224 | 9,191 |
| Net Income Continuous | -3,827 | 1,168 | -9,156 | 1,224 | 9,191 |
| Net Income | $-3,827 | $1,168 | $-9,156 | $1,224 | $9,191 |
| EPS Basic Total Ops | -0.27 | 0.08 | -0.64 | 1.44 | 2.67 |
| EPS Basic Continuous Ops | -0.27 | 0.08 | -0.64 | -4.64 | 6.82 |
| EPS Diluted Total Ops | -0.27 | -0.07 | -0.64 | 1.59 | 1.69 |
| EPS Diluted Continuous Ops | -0.27 | 0.08 | -0.64 | -2.98 | 4.33 |
| EBITDA(a) | $-558 | $484 | $-5,930 | $240 | $8,844 |